RECITALSSettlement and Modification Agreement • December 21st, 2004 • Vitrotech Corp • Mining & quarrying of nonmetallic minerals (no fuels) • California
CONFIDENTIAL SETTLEMENT AND MODIFICATION AGREEMENTSettlement and Modification Agreement • February 25th, 2021 • Anaptysbio, Inc • Pharmaceutical preparations • Delaware
This Confidential Settlement and Modification Agreement (the “Agreement”) is made and entered into on the date that it is signed by the last of the signatories identified below (the “Effective Date”), by and between (i) AnaptysBio, Inc., a Delaware corporation having its principal place of business at 10421 Pacific Center Court, Suite 200, San Diego, CA 92121 (“AnaptysBio”), (ii) Tesaro, Inc., a Delaware corporation having its principal place of business in 1000 Winter Street, Waltham, Massachusetts 02451, (iii) Tesaro Development, Ltd., a Bermuda corporation having its principal office at Clarendon House, 2 Church Street, Hamilton HM 11, Bermuda (together with Tesaro, Inc., “Tesaro”), and (iv) GlaxoSmithKline LLC, a Delaware limited liability corporation having its principal place of business at 5 Crescent Drive, Philadelphia, PA 19112 (“GSK”) (Tesaro and GSK, collectively, “Defendants”) (each individually the “Party” or collectively the “Parties”).
BACKGROUNDSettlement and Modification Agreement • August 9th, 2001 • Vivus Inc • Surgical & medical instruments & apparatus • Delaware
